New Jersey v. Olenowski
Annotate this CaseThe New Jersey Supreme Court granted certification to decide “whether the testimony of an officer who is a certified Drug Recognition Expert (DRE) is admissible at trial and, if so, under what circumstances.” At the heart of the case was whether there was a reliable scientific basis for a twelve-step protocol that is used to determine (1) whether a person was impaired, and (2) whether that impairment was likely caused by ingesting one or more drugs. For decades, issues like this in criminal cases were analyzed under the test outlined in Frye v. United States, 293 F. 1013 (D.C. Cir. 1923). That standard turned on whether the subject of expert testimony was “generally accepted” in the relevant scientific community. The New Jersey Court moved away from the Frye test over time. In civil cases, New Jersey shifted toward an approach that focused directly on reliability by evaluating the methodology and reasoning underlying proposed expert testimony. After an extensive evidentiary hearing before a Special Master, the Court asked the parties and amici to submit their views on whether to depart from Frye and adopt the principles of Daubert in criminal cases. After review, the Court concluded Daubert offered a superior approach to evaluate the reliability of expert testimony. This case was remanded back to the Special Master to apply the standard announced here to the DRE evidence in the first instance.